Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Ferguson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Biolaw & Business|September 30, 2011
Products, Partners & Public Health: Transfer of Biomedical Technologies from the U.S. GovernmentSteven M Ferguson
LES Nouvelles. Licensing Executives Society (U.S.A.)|April 10, 2023
An Early TTO For U.S. Federal Labs-The National Technical Information ServiceSteven M Ferguson
Journal of Commercial Biotechnology|March 12, 2013
Partnering with the NIH: Now part of the "Value Proposition" for start-upsSteven M Ferguson
LES Nouvelles. Licensing Executives Society (U.S.A.)|May 29, 2026
Technology Licensing & Commercialization Considerations for Clinical ScientistsSteven M Ferguson, Jack Spiegel
Drug Discovery Today|January 28, 2003
Distribution and licensing of drug discovery tools--NIH perspectivesSteven M Ferguson, J P Kim
The Journal of Biolaw & Business|October 1, 2011
Commercial Licensing of HIV-1 Protease: Applications of the NIH Research Tools PolicyGeorge H Keller, Steven M Ferguson
Tomorrow'S Technology Transfer|June 15, 2010
Research Discoveries After KubinNancy W Vensko, Steven M Ferguson
Journal of Commercial Biotechnology|April 16, 2021
The U.S. National Institutes of Health - Founding A National Biomedical "Innovation Ecosystem"Steven M Ferguson, Lynn Johnson Langer
Journal of Commercial Biotechnology|November 11, 2017
A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug DevelopmentBerna Uygur, Josh Duberman, Steven M Ferguson
Current Drug Discovery Technologies|February 16, 2006
Nature's medicines: traditional knowledge and intellectual property management. Case studies from the National Institutes of Health (NIH), USARanjan Gupta, Bjarne Gabrielsen, Steven M Ferguson
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Biolaw & Business|September 30, 2011
Products, Partners & Public Health: Transfer of Biomedical Technologies from the U.S. GovernmentSteven M Ferguson
LES Nouvelles. Licensing Executives Society (U.S.A.)|April 10, 2023
An Early TTO For U.S. Federal Labs-The National Technical Information ServiceSteven M Ferguson
Journal of Commercial Biotechnology|March 12, 2013
Partnering with the NIH: Now part of the "Value Proposition" for start-upsSteven M Ferguson
LES Nouvelles. Licensing Executives Society (U.S.A.)|May 29, 2026
Technology Licensing & Commercialization Considerations for Clinical ScientistsSteven M Ferguson, Jack Spiegel
Drug Discovery Today|January 28, 2003
Distribution and licensing of drug discovery tools--NIH perspectivesSteven M Ferguson, J P Kim
The Journal of Biolaw & Business|October 1, 2011
Commercial Licensing of HIV-1 Protease: Applications of the NIH Research Tools PolicyGeorge H Keller, Steven M Ferguson
Tomorrow'S Technology Transfer|June 15, 2010
Research Discoveries After KubinNancy W Vensko, Steven M Ferguson
Journal of Commercial Biotechnology|April 16, 2021
The U.S. National Institutes of Health - Founding A National Biomedical "Innovation Ecosystem"Steven M Ferguson, Lynn Johnson Langer
Journal of Commercial Biotechnology|November 11, 2017
A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug DevelopmentBerna Uygur, Josh Duberman, Steven M Ferguson
Current Drug Discovery Technologies|February 16, 2006
Nature's medicines: traditional knowledge and intellectual property management. Case studies from the National Institutes of Health (NIH), USARanjan Gupta, Bjarne Gabrielsen, Steven M Ferguson
Pageof 2